4//SEC Filing
Devlin Jodi 4
Accession 0001209191-23-047894
CIK 0001826667other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 9:04 PM ET
Size
5.6 KB
Accession
0001209191-23-047894
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Employee Stock Option (right to buy)
2023-08-30+195,000→ 195,000 totalExercise: $6.70Exp: 2033-08-29→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of August 28, 2023, and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the vesting commencement date.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001992151
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 9:04 PM ET
- Size
- 5.6 KB